-
Tesla Shares Rise As UBS Doubles Price Target
Friday, September 11, 2020 - 9:53am | 302Tesla Inc (NASDAQ: TSLA) shares traded higher by as much as 3% premarket Friday after UBS doubled its one-year price target for the stock from $160 to $325 in anticipation of Tesla's battery day announcements Sept. 22. Why UBS Lifted Its Tesla Forecast: Analyst Patrick...
-
Sports Illustrated's Lost Ad Revenue, Layoffs Hit Maven's Stock Hard
Wednesday, April 1, 2020 - 4:20pm | 256TheMaven Inc (OTC: MVEN) shares traded sharply lower on Wednesday on news the company will lay off 9% of its staff and initiate cost-containment measures. The company is the publisher of Sports Illustrated and TheStreet. TheMaven announced late Monday a wide-ranging cost-containment plan...
-
2 Dow Stocks Surviving The Coronavirus Carnage
Monday, March 16, 2020 - 3:02pm | 354The Dow Jones Industrial Average came 400 points of falling to the 20,000 mark Monday, and even after a minor rebound, the index is still down a massive 2,000 points, or more than 9%. Two Dow components were standing out amid the wreckage: Caterpillar Inc. (NYSE: CAT) and Walgreens Boots...
-
Here's Who Could Take A Massive Hit If The 2020 Olympics Were Canceled
Friday, February 28, 2020 - 9:15am | 478The 2020 Summer Olympics are scheduled to be held in Tokyo, Japan from July 24 to Aug. 9. International Olympic Committee member Dick Pound told the Associated Press Tuesday that a decision on whether to cancel the Olympics due to the COVID-19 virus outbreak will need to be made by May....
-
Roku 'Will Find A Ready Market Abroad,' Macquarie Says In Upgrade
Wednesday, October 9, 2019 - 10:22am | 426Roku Inc (NASDAQ: ROKU) has settled 36% below the all-time high it struck in September, and one analyst sees a buying opportunity. The Analyst Macquarie analyst Timothy Nollen upgraded Roku from Neutral to Outperform and raised the price target from $110 to $130. The Thesis Nollen sees 20%...
-
Goldman Sachs Raises Netflix Price Target To $490, Projects Positive Cash Flow By 2022
Wednesday, June 13, 2018 - 1:32pm | 390One of Netflix, Inc. (NASDAQ: NFLX)'s biggest negatives is free cash flow, but it's a concern that will subside as the company exits 2018, according to Goldman Sachs. The Analyst Goldman Sachs' Heath Terry maintained a Buy rating on Netflix's stock with a price...
-
JD Sports' $588-Million Finish Line Purchase Is Positive For Both Companies
Tuesday, March 27, 2018 - 4:44pm | 641After several months of speculation, Finish Line Inc (NASDAQ: FINL) announced it has been acquired by a U.K. retailer, but not the one that was previously named. JD Sports, known as one of the premier footwear retailers in the U.K., has purchased the Indianapolis-based footwear retailer for $588...
-
AMC Shares Slammed Amid Q2 Warning; Loop Cuts Target But Maintains Buy
Wednesday, August 2, 2017 - 9:45am | 482AMC Entertainment Holdings Inc (NYSE: AMC) shocked investors on Tuesday with a second-quarter preannouncement, which look "particularly ugly," according to Loop Capital Markets' David Miller. Yet despite a 25 percent plunge in AMC's stock the analyst is parting ways with his bullish stance as he...
-
Blue Apron's Stock Is Getting Crushed Amid Reports Of Amazon Meal Kit Trademark
Monday, July 17, 2017 - 9:42am | 339Blue Apron Holdings Inc (NYSE: APRN) IPO in late June couldn't have come at a worse time. The company sells to consumers a food delivery kit, but it's far from alone in the space and faces competition from several other startups. An even bigger threat is the possibility of Amazon.com, Inc...
-
Explaining The Interconnected Fates Of The World's Most Profitable Tech Firms
Thursday, July 13, 2017 - 11:40am | 545In a world that’s been described as dog-eat-dog, where “survival of the fittest” and like cliches abound, business competition is fierce. With limited resources and limited customers, some companies, like the people running them, have found strategic treaties and partnerships...
-
Walgreens–Rite Aid Deal In Its Final Act
Thursday, June 15, 2017 - 2:31pm | 1359A deal announced over 1.5 years ago still hangs in the balance. Whether the deal clears the regulatory hurdle has become a heated debate in itself. With the passing of each day, pessimism is abounding, with the scuttling of a few mega healthcare deals throwing in the possibility of the...
-
A Former Sears Exec Just Trashed The Company's Current Management
Thursday, June 8, 2017 - 1:48pm | 399Sears Holdings Corp (NASDAQ: SHLD) is fighting hard to remain relevant in the retail environment, but at least one former executive isn't offering any moral support or encouragement. In an interview with TheStreet, Sears Canada's former CEO Mark Cohen blasted the company, including its most senior...
-
Exondys Sales, Takeover Speculation Fuel Sarepta Therapeutics
Friday, April 28, 2017 - 11:31am | 380Sarepta Therapeutics Inc (NASDAQ: SRPT) shares are up more than 6.5 percent Friday after the company reported first-quarter net revenue from EXONDYS 51 of $16.3 million and guided for $95 million in revenue for the full year, up from previous guidance of $80 million. In addition to the revenue beat...
-
Here's Why Corbus Pharmaceuticals Fell 10% Thursday Morning
Thursday, March 30, 2017 - 9:56am | 390Shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) were trading lower by around 10 percent Thursday morning, even though the company reported positive, top-line data from an ongoing clinical trial. Corbus has been exploring its Anabasum (Resunab) therapy in a Phase 2 study for the...
-
6 Tweets Tell The Aurinia Pharma Story
Tuesday, March 14, 2017 - 3:48pm | 665Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) shares are down more than 20 percent Tuesday after nearly tripling in a month’s time. For traders wondering how the stock lost its mojo, the Twitter feed of TheStreet columnist Adam Feuerstein tells the story. Related Link: 7 Tweets That Ruined...